Zimmer Biomet reported quarterly EPS of $2.09, beating the Zacks Consensus Estimate of $1.86 by $0.23 per share. Earnings also improved from $1.81 a year ago, indicating year-over-year profit growth. The print is a solid earnings beat that could modestly support ZBH shares.
Zimmer Biomet reported quarterly EPS of $2.09, beating the Zacks Consensus Estimate of $1.86 by $0.23 per share. Earnings also improved from $1.81 a year ago, indicating year-over-year profit growth. The print is a solid earnings beat that could modestly support ZBH shares.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
